impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

Full Papers

 

Evaluation of collected outcome measures in axial spondyloarthritis in daily-care rheumatology settings: the experience of the RHEVER network

1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24

 

  1. Hôpital Cochin, Assistance Publique, Hôpitaux de Paris, Département de Rhumatologie, Paris, and Hôpital Lapeyronie, Département de Rhumatologie, Montpellier, France. che.helene@yahoo.fr
  2. Hôpital Cochin, Assistance Publique, Hôpitaux de Paris, Département de Rhumatologie, Paris, France.
  3. Centre Hospitalier du Mans, Service de Rhumatologie, Le Mans, France.
  4. Private office, 57 boulevard du Marechal Juin, 78200 Mantes la Jolie, France.
  5. Polyclinique de Picardie, Service de Rhumatologie, Amiens, France.
  6. Private office, 10 rue Claret, 95500 Gonesse, France
  7. Private office, 98 boulevard Auguste Blanqui, 75013 Paris, France.
  8. Private office, 1 rue Hoche, 93500 Pantin, France.
  9. Hôpital Cochin, Assistance Publique, Hôpitaux de Paris, Département de Rhumatologie, Paris; and Private office, 4 place Jules Ferry, 91240 St Michel sur Orge, France.
  10. Private office, 10 rue Henri Amodru, 91190 Gif sur Yvette, France.
  11. Private office, 5 square du Roule, 75008 Paris, France.
  12. Private office, 18 rue Fabre d’Eglantine, 75012 Paris, France.
  13. Private office, Cabinet Médical de l’Olivier, 2bis rue Stephanson, 78180 Montigny le Bretonneux, France.
  14. Private office, 118, rue Jean Jaurès, 92800 Puteaux, France.
  15. Private office, 5 square du Roule, 75008 Paris, France.
  16. Private office, 4 boulevard Beaumarchais, 75011 Paris, France.
  17. Private office, 5 square du Roule, 75008 Paris, France.
  18. Private office, 65 boulevard de Courcelles, 75008 Paris, France.
  19. Hôpital François Quesnay, Service de Rhumatologie, Mantes la Jolie, France.
  20. Hôpital Cochin, Assistance Publique, Hôpitaux de Paris, Département de Rhumatologie, Paris, France.
  21. Hôpital Cochin, Assistance Publique, Hôpitaux de Paris, Département de Rhumatologie, Paris, France.
  22. Hôpital Cochin, Assistance Publique, Hôpitaux de Paris, Département de Rhumatologie, Paris, France.
  23. Hôpital Cochin, Assistance Publique, Hôpitaux de Paris, Département de Rhumatologie, Paris; and INSERM (U1153), Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, France.
  24. Hôpital Cochin, Assistance Publique, Hôpitaux de Paris, Département de Rhumatologie, Paris; and INSERM (U1153), Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, France.

CER8372
2015 Vol.33, N°6
PI 0851, PF 0857
Full Papers

Free to view
(click on article PDF icon to read the article)

PMID: 26411931 [PubMed]

Received: 15/02/2015
Accepted : 28/05/2015
In Press: 28/09/2015
Published: 15/12/2015

Abstract

OBJECTIVES:
Nowadays, the recommended measures for optimal monitoring of axial Spondyloarthritis (ax-SpA) disease activity are either BASDAI and CRP, or ASDAS-CRP. However, there could be a gap between recommendations and daily practice. We aimed to determine the measures collected by rheumatologists in an ax-SpA follow-up visit, and to determine the impact of a meeting (where rheumatologists reached a consensus on the measures to be collected) on the collection of such measures.
METHODS:
A consensual meeting of a local network of 32 rheumatologists proposed, four months later, to report at least the BASDAI score in the medical file of every ax-SpA patient at every follow-up visit. An independent investigator reviewed the medical files of 10 consecutive patients per rheumatologist, seen twice during the year (e.g. before and after the meeting). The most frequently collected measures were assessed, and then, the frequency of collection before and after the meeting was compared.
RESULTS:
A total of 456 medical files from 228 patients were reviewed. Treatment (>60%), CRP (51.3%) and total BASDAI (28.5%) were the most reported measures in medical files. Before/After the meeting, the frequencies of collected measures in medical files were 28.5%/51.7%, 51.3%/52.2%, 16.7%/31.6% and 0.9%/6.1% for BASDAI, CRP, BASDAI + CRP and ASDAS, respectively reaching a statistically significance for BASDAI, ASDAS and BASDAI+CRP (p<0.05).
CONCLUSIONS:
This study revealed a low rate of systematic report of the recommended outcome measures in ax-SpA. However, it suggests that a consensual meeting involving practicing rheumatologists might be relevant to improve the implementation of such recommendations.

Rheumatology Article